SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Incannex Healthcare reports quarterly adjusted loss of A$11.23 per share

Revenue was zero and the quarterly loss was A$5.59 million. The lone analyst forecast had been for a 75-cent-per-share loss.

IXHL.O

Incannex Healthcare Inc reported an adjusted quarterly loss of A$11.23 per share for the quarter ended June 30, compared with A$-238.98 a year earlier. The lone analyst estimate was for a loss of 75 cents per share. Revenue came in at zero, matching expectations. The company said reported EPS for the quarter was a loss of A$12.60, and quarterly loss was A$5.59 million.

Incannex Healthcare shares were down 11.7% in the quarter and had fallen 69.1% year to date. Analysts' mean earnings estimate was unchanged over the past 30 days, with no estimate revisions in the last 30 days. The average analyst rating is buy, based on 1 strong buy or buy recommendation, no hold and no sell or strong sell. The biotechnology & medical research peer group also has an average buy recommendation.

Wall Street's median 12-month price target is $18.00, or 81.6% above the last closing price of $3.32. Machine-generated LSEG data dated September 28 at 12:37 p.m. UTC shows figures in Australian dollars unless otherwise stated. For the quarter ended Jun.

30 2026, the estimate was -0.93 and the actual was -0.20, marked Beat. For the quarter ended Mar. 31 2026, the estimate was -0.93 and the actual was -22.83, marked Missed. For the quarter ended Dec.

31 2025, the estimate was -0.93 and the actual was -22.83, marked Missed. For the quarter ended Jun. 30 2025, the estimate was -0.93 and the actual was -22.95, marked Missed.

Related stories